Tasso Ranks No. 317 on Deloitte Fast 500

The Seattle healthcare technology company was named among North America's fastest-growing technology firms in the 2026 Deloitte ranking.

Updated on Nov. 18, 2026 in Industry

Tasso Ranks No. 317 on Deloitte Fast 500

Tasso, Inc., a healthcare technology company headquartered in Seattle, Washington, ranked No. 317 on the 2026 Deloitte Technology Fast 500. The company grew revenue 200% from 2022 to 2025.

Why it matters

The ranking highlights growth in a company that produces capillary blood collection devices used in research and healthcare settings as an alternative to traditional venipuncture. For Seattle, it adds a locally headquartered healthcare technology firm to the city's list of recognized high-growth companies.

Tasso's revenue grew 200% from 2022 to 2025, placing it at No. 317 among the 500 fastest-growing technology, media, telecommunications, life sciences, fintech and energy tech companies in North America. The source does not disclose Tasso's absolute revenue or profit figures.

The players

Tasso, Inc.

A privately held healthcare technology company headquartered in Seattle that makes capillary blood collection devices and is funded by grants, investments and co-development deals.

Deloitte

A multinational professional services firm that publishes the annual Technology Fast 500 ranking of fast-growing North American companies.

The details

Tasso's push-button devices attach to the upper arm to collect capillary blood, a method the company positions as an alternative to traditional venipuncture that requires a trained phlebotomist. Growth came from research organizations, laboratories and healthcare partners, including an expansion into Japan through a joint venture with Shin Nippon Biomedical Laboratories, Ltd. and regulatory clearances for the Tasso Mini in the European Union and Canada.

Timeline

  1. 2022 to 2025: Tasso's revenue grew 200% over the ranking period.

  2. Paris 2024: Tasso blood collection was used at the Paris Olympic Games.

  3. 2026: Tasso was named No. 317 on the 2026 Deloitte Technology Fast 500.

  4. 2026 Olympic Winter Games: Tasso anti-doping blood collection was used at the Games.

Healthcare Landscape

Tasso's growth reflects the shift toward decentralized blood collection that the company argues can replace clinic-based venipuncture for research and testing. The ranking places a Seattle device maker alongside other life sciences firms recognized by Deloitte's Technology Fast 500.

Capillary collection devices like Tasso's can reduce the need for an in-person visit and a trained phlebotomist for some blood tests. The source does not state whether the devices are available to individual patients or only to research and healthcare partners.

The takeaway

Growth in decentralized blood collection shows how healthcare testing is moving closer to where people live and work. Readers interested in this shift can track how research and clinical partners adopt these tools over the coming years.

Further reading

Explore more Seattle healthcare industry coverage to see how local companies are shaping medical technology.

More information

View the full 2026 Deloitte Technology Fast 500 rankings for the complete list of ranked companies.

Source note: This article includes information reported by Jiji.